The intermediary metabolite pyruvate attenuates stunning and reduces infarct size in in vivo porcine myocardium

The intermediary metabolite pyruvate has been shown to exert significant beneficial effects in in vitro models of myocardial oxidative stress and ischemia-reperfusion injury. However, there have been few reports of the ability of pyruvate to attenuate myocardial stunning or reduce infarct size in vivo. This study tested whether supraphysiological levels of pyruvate protect against reversible and irreversible in vivo myocardial ischemia-reperfusion injury. Anesthetized, open-chest pigs (n = 7/group) underwent 15 min of left anterior descending coronary artery (LAD) occlusion and 3 h of reperfusion to induce stunning. Load-insensitive contractility measurements of regional preload recruitable stroke work (PRSW) and PRSW area (PRSWA) were generated. Vehicle or pyruvate (100 mg/kg i.v. bolus + 10 mg x kg(-1) x min(-1) intra-atrial infusion) was administered during ischemia and for the first hour of reperfusion. In infarct studies, pigs (n = 6/group) underwent 1 h of LAD ischemia and 3 h of reperfusion. Group I pigs received vehicle or pyruvate for 30 min before and throughout ischemia. In group II, the infusion was extended through 1 h of reperfusion. In the stunning protocol, pyruvate significantly improved the recovery of PRSWA at 1 h (50 +/- 4% vs. 23 +/- 3% in controls) and 3 h (69 +/- 5% vs. 39 +/- 3% in controls) reperfusion. Control pigs exhibited infarct sizes of 66 +/- 1% of the area at risk. The pyruvate I protocol was associated with an infarct size of 49 +/- 3% (P < 0.05), whereas the pyruvate II protocol was associated with an infarct size of 30 +/- 2% (P < 0.05 vs. control and pyruvate I). These findings suggest that pyruvate attenuates stunning and decreases myocardial infarction in vivo in part by reduction of reperfusion injury. Metabolic interventions such as pyruvate should be considered when designing the optimal therapeutic strategies for limiting myocardial ischemia-reperfusion injury.     

免疫毒素Luffin B-Ng76对人黑色素瘤细胞的体外抑制作用

用ＢｌｕｅＳｅｐｈａｒｏｓｅＣＬ－６Ｂ凝胶亲和层析法从丝瓜籽中分离纯化了单链致核糖体失活蛋白（ｒｉｂｏｓｏｍｅｉｎａｃ－ｔｉｖａｔｉｎｇｐｒｏｔｅｉｎ,ＲＩＰ）——ｌｕｆｉｎＢ。并将ｌｕｆｉｎＢ与抗人黑色素瘤细胞单抗Ｎｇ７６制成了免疫毒素,命名为ｌｕｆｉｎＢ－Ｎｇ７６,它对体外培养的黑色素瘤细胞Ｍ２１有很强的抑制作用,ＩＣ５０为２．５×１０－１１ｍｏｌ／Ｌ,毒性比游离的ｌｕｆｉｎＢ提高４０００倍,而它对非靶的ＨｅＬａ细胞的毒性较Ｍ２１细胞低１２００倍。结果提示ｌｕｆｉｎＢ用于制备免疫毒素具有良好的应用前景。     

毛梗希莶的化学成分

从毛梗希莶的乙醇提取物分到胡萝卜甙和３个二萜类成分,根据光谱和化学证据,３个二萜的化学结构被分别确定为：对映－１４β,１７－二羟基贝壳杉烷－１９－腺梗希莶甙和希莶甙。对映二羟基－１６β,１７－贝壳杉烷－酸和腺梗希莶甙系首次从毛梗希莶中到。     

刺激黄雀新纹状体前部大细胞核外侧部对发声和呼吸的影响

实验材料为乌拉坦麻醉的鸣禽黄雀（Ｃａｒｄｕｅｌｉｓ ｓｐｉｎｕｓ）。观察了电及化学刺激新纹状体前部大细胞核外侧部（１ＭＡＮ）对发声和呼吸的影响。结果如下：（１）电刺激１ＭＡＮ的不同区域都引起鸣叫反应。（２）长串电脉冲刺激１ＭＡＮ使呼吸频率增加,呼吸幅度降低。（３）短串电脉冲刺激１ＭＡＮ,落位于吸气相,产生吸气要断效应;落位于呼气相,可使呼气时程延长,以冲刺激１ＭＡＮ,落位于吸气相,产生吸气切断效应     

温度对红点唇瓢虫实验种群的影响

在７种温度下测定了红点唇瓢虫（Ｃｈｉｌｏｃｏｒｕｓ ｋｕｗａｎａｅ Ｓｉｌｖｅｓｔｒｉ）发育速率,并求得各虫态的发育起点温度和有效积温。其发育速率与温度的关系能很好地用王如松等（１９８２）提出的模型进行拟合。由此模型估计出最低、最高临界温度和最适发育温度,分别为１０．４２－１３．０１－℃、℃３３．５３－３７．０３℃和２４．９９－３０．１２℃。卵期忍耐温度变化的能力最强。４龄幼虫最弱。温度明显地影响     

Photosan脂质立方液晶纳米光敏剂的制备及光动力杀伤效应研究

目的:制备Photosan脂质立方液晶纳米光敏剂,通过体外实验探讨其介导的光动力疗法(photodynamic therapy,PDT)特异性杀伤肿瘤细胞效果。方法:以单油酸甘油酯(glyceryl monooleate,GMO)和泊洛沙姆407(poloxamer 407,P407)为液晶材料,以光敏剂Photosan为模型药物,制备Photosan立方液晶纳米粒,通过Malvern粒径仪和扫描电子显微镜等考察其理化性质;通过MTS法考察Photosan立方液晶纳米粒对正常肝细胞株和肝癌细胞株的暗毒性及光动力杀伤效果。结果:成功制备Photosan脂质立方液晶纳米粒,该纳米粒对人肝L-02细胞和人肝癌Hep G2细胞均没有暗毒性,其介导的PDT对人肝L-02细胞增殖有一定抑制作用[细胞抑制率为(32.9±1.19)%],而对肝癌Hep G2细胞增殖具有更显著的抑制作用[细胞抑制率为(77.9±2.06)%];Photosan立方液晶介导的光动力作用对人正常肝细胞的增殖抑制作用低于Photosan,但对肝癌细胞的增殖抑制作用高于Photosan。结论:Photosan脂质立方液晶纳米粒对人正常肝细胞安全性较好,对肝癌细胞的光动力杀伤效应明显优于Photosan,为光动力治疗癌症提供了创新性方法。     

基于SSR和ISSR的鄱阳湖流域野生菰资源的遗传多样性分析

用SSR和ISSR标记对鄱阳湖流域30个野生菰居群的遗传多样性与遗传结构进行了分析。筛选出的19对SSR引物共扩增出多态性条带253条,平均多态性条带比率(PPB)为91.67%,Nei's基因多样性指数(He)和平均Shannon信息指数(I)分别为0.2712和0.4144,遗传相似性系数(GS)为0.5590~0.8368,遗传距离(GD)的变化范围为0.1632~0.4410;筛选出的14个ISSR标记引物共扩增出83条条带,平均多态性条带比率(PPB)为78.29%,Nei's基因多样性指数(He)和平均Shannon信息指数(I)分别为0.2386和0.4174,遗传相似性系数(GS)为0.5132~0.9342,遗传距离(GD)变化范围为0.0658~0.4868。根据SSR和ISSR基因型数据,采用UPGMA法分别在阈值为0.698和0.728时可将30个野生菰居群聚为3类。可能受人为、水流、动物活动、风等多种因素的影响,居群间的亲缘关系与地理分布无明显相关性。本研究表明,鄱阳湖流域野生菰居群间SSR和ISSR基因型的多样性丰富,居群间的这种遗传差异或变异,对该地区乃至更大范围内野生菰的遗传进化、基因资源的开发利用和种质资源的保护有着重要意义。     

八氢番茄红素合成酶(PSY)的生物信息学分析

目的:通过生物信息学方法对八氢番茄红素合成酶基因(PSY)及氨基酸序列分析,并构建三维结构。方法:运用生物信息学方法对八氢番茄红素合成酶基因及其蛋白质序列的理化性质、亲/疏水性、信号肽、跨膜结构域、糖基化位点,磷酸化位点,二级结构,功能结构域和三级结构进行预测分析。结果:PSY基因含1239bp的开放阅读框,编码氨基酸数为412,为碱性不稳定蛋白;八氢番茄红素合成酶富含Arg、Leu、Ala、Ser、Val等氨基酸,为亲水性蛋白质;PSY为非跨膜蛋白,不含信号肽,具有多个磷酸化位点,α螺旋和无规卷曲是其主要结构元件。结论:用同源建模的方法构建其三维结构,得到合理模型,为采用生物工程提高番茄红素产量提供理论依据。     

Liquid-Solid Phase-Inversion PLGA Implant for the Treatment of Residual Tumor Tissue after HIFU Ablation

BackgroundHIFU has been shown to be a more suitable alternative for the treatment of primary solid tumors and metastatic diseases than other focal heat ablation techniques due to its noninvasive and extracorporeal nature. However, similar to other focal heat ablation techniques, HIFU is still in need of refinements due to tumor recurrence.MethodsIn this work, we investigated the effectiveness of an adjunct treatment regimen using doxorubicin (DOX)-loaded, injectable, in situ-forming, and phase-inverting PLGA as the second line of defense after HIFU ablation to destroy detrimental residual tumors and to prevent tumor recurrence. All of the statistical analyses were performed using the Statistical Package for the Social Sciences 18.0(SPSS, Inc., Chicago, IL, USA), and p< 0.05 was considered statistically significant. All of the results are presented as the means ± STDEV (standard deviation). For multiple comparisons, ANOVA (differences in tumor volumes, growth rates, apoptosis, proliferation indexes, and Bcl-2 and Bax protein levels) was used when the data were normally distributed with homogenous variance, and rank sum tests were used otherwise. Once significant differences were detected, Student-t tests were used for comparisons between two groups.ResultsOur results revealed that DOX diffused beyond the ablated tissue regions and entered tumor cells that were not affected by the HIFU ablation. Our results also show that HIFU in concert with DOX-loaded PLGA led to a significantly higher rate of tumor cell apoptosis and a lower rate of tumor cell proliferation in the areas beyond the HIFU-ablated tissues and consequently caused significant tumor volume shrinkage (tumor volumes:0.26±0.1,1.09±0.76, and 1.42±0.9cm³ for treatment, sham, and no treatment control, respectively).ConclusionsFrom these results, we concluded that the intralesional injection of DOX-loaded PLGA after HIFU ablation is significantly more effective than HIFU alone for the treatment of solid tumors.